Diphenoxylate
Lomotil (diphenoxylate) is a small molecule pharmaceutical. Diphenoxylate was first approved as Lomotil on 1982-01-01. It is used to treat diarrhea in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Combinations
Lomotil (generic drugs available since 1982-01-01, discontinued: Colonaid, Di-atro, Lo-trol, Logen, Lomanate, Lonox, Low-quel)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Atropine sulfate
+
Diphenoxylate hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LOMOTIL | Mylan | N-012462 RX | 1982-01-01 | 1 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
diphenoxylate hydrochloride and atropine sulfate | ANDA | 2023-06-13 |
lomotil | New Drug Application | 2022-04-01 |
sore throat logenzes | OTC monograph not final | 2021-11-10 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
diarrhea | HP_0002014 | D003967 | R19.7 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details

Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Vertigo | D014717 | H81.39 | — | — | — | 1 | — | 1 | |
Meniere disease | D008575 | EFO_0006862 | H81.0 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | DIPHENOXYLATE |
INN | diphenoxylate |
Description | Diphenoxylate is a piperidinecarboxylate ester that is the ethyl ester of difenoxin. It has a role as an antidiarrhoeal drug. It is a nitrile, a piperidinecarboxylate ester, a tertiary amine and an ethyl ester. It is functionally related to a difenoxin. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1 |
Identifiers
PDB | — |
CAS-ID | 915-30-0 |
RxCUI | 3500 |
ChEMBL ID | CHEMBL1201294 |
ChEBI ID | 4639 |
PubChem CID | 13505 |
DrugBank | DB01081 |
UNII ID | 73312P173G (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,714 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
35 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more